These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 18477606

  • 21. The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.
    Ford-Speelman DL, Roche JA, Bowman AL, Bloch RJ.
    Mol Biol Cell; 2009 Sep; 20(17):3905-17. PubMed ID: 19605563
    [Abstract] [Full Text] [Related]

  • 22. Binding partners of the kinase domains in Drosophila obscurin and their effect on the structure of the flight muscle.
    Katzemich A, West RJ, Fukuzawa A, Sweeney ST, Gautel M, Sparrow J, Bullard B.
    J Cell Sci; 2015 Sep 15; 128(18):3386-97. PubMed ID: 26251439
    [Abstract] [Full Text] [Related]

  • 23. Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum.
    Armani A, Galli S, Giacomello E, Bagnato P, Barone V, Rossi D, Sorrentino V.
    Exp Cell Res; 2006 Nov 01; 312(18):3546-58. PubMed ID: 16962094
    [Abstract] [Full Text] [Related]

  • 24. Fishing out proteins that bind to titin.
    Sanger JW, Sanger JM.
    J Cell Biol; 2001 Jul 09; 154(1):21-4. PubMed ID: 11448986
    [Abstract] [Full Text] [Related]

  • 25. Localization of ank1.5 in the sarcoplasmic reticulum precedes that of SERCA and RyR: relationship with the organization of obscurin in developing sarcomeres.
    Giacomello E, Sorrentino V.
    Histochem Cell Biol; 2009 Mar 09; 131(3):371-82. PubMed ID: 19002483
    [Abstract] [Full Text] [Related]

  • 26. Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.
    Borisov AB, Sutter SB, Kontrogianni-Konstantopoulos A, Bloch RJ, Westfall MV, Russell MW.
    Histochem Cell Biol; 2006 Mar 09; 125(3):227-38. PubMed ID: 16205939
    [Abstract] [Full Text] [Related]

  • 27. Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin.
    Sauer F, Vahokoski J, Song YH, Wilmanns M.
    EMBO Rep; 2010 Jul 09; 11(7):534-40. PubMed ID: 20489725
    [Abstract] [Full Text] [Related]

  • 28. Translocation of molecular chaperones to the titin springs is common in skeletal myopathy patients and affects sarcomere function.
    Unger A, Beckendorf L, Böhme P, Kley R, von Frieling-Salewsky M, Lochmüller H, Schröder R, Fürst DO, Vorgerd M, Linke WA.
    Acta Neuropathol Commun; 2017 Sep 15; 5(1):72. PubMed ID: 28915917
    [Abstract] [Full Text] [Related]

  • 29. CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy.
    Charton K, Sarparanta J, Vihola A, Milic A, Jonson PH, Suel L, Luque H, Boumela I, Richard I, Udd B.
    Hum Mol Genet; 2015 Jul 01; 24(13):3718-31. PubMed ID: 25877298
    [Abstract] [Full Text] [Related]

  • 30. When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein-protein interactions and protein stability.
    Fukuzawa A, Koch D, Grover S, Rees M, Gautel M.
    Hum Mol Genet; 2021 Jun 09; 30(12):1131-1141. PubMed ID: 33438037
    [Abstract] [Full Text] [Related]

  • 31. Nuclear localization of Myomesin-1: possible functions.
    Reddy KB, Fox JE, Price MG, Kulkarni S, Gupta S, Das B, Smith DM.
    J Muscle Res Cell Motil; 2008 Jun 09; 29(1):1-8. PubMed ID: 18521710
    [Abstract] [Full Text] [Related]

  • 32. Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies.
    Sarparanta J, Blandin G, Charton K, Vihola A, Marchand S, Milic A, Hackman P, Ehler E, Richard I, Udd B.
    J Biol Chem; 2010 Sep 24; 285(39):30304-15. PubMed ID: 20634290
    [Abstract] [Full Text] [Related]

  • 33. Different domains of the M-band protein myomesin are involved in myosin binding and M-band targeting.
    Auerbach D, Bantle S, Keller S, Hinderling V, Leu M, Ehler E, Perriard JC.
    Mol Biol Cell; 1999 May 24; 10(5):1297-308. PubMed ID: 10233145
    [Abstract] [Full Text] [Related]

  • 34. M line-deficient titin causes cardiac lethality through impaired maturation of the sarcomere.
    Weinert S, Bergmann N, Luo X, Erdmann B, Gotthardt M.
    J Cell Biol; 2006 May 22; 173(4):559-70. PubMed ID: 16702235
    [Abstract] [Full Text] [Related]

  • 35. Structural Insights on the Obscurin-Binding Domains in Titin.
    Letourneau AG, Wright NT.
    Protein Pept Lett; 2018 May 22; 25(11):973-979. PubMed ID: 30289063
    [Abstract] [Full Text] [Related]

  • 36. Obscurin is a ligand for small ankyrin 1 in skeletal muscle.
    Kontrogianni-Konstantopoulos A, Jones EM, Van Rossum DB, Bloch RJ.
    Mol Biol Cell; 2003 Mar 22; 14(3):1138-48. PubMed ID: 12631729
    [Abstract] [Full Text] [Related]

  • 37. Biophysical characterization of naturally occurring titin M10 mutations.
    Rudloff MW, Woosley AN, Wright NT.
    Protein Sci; 2015 Jun 22; 24(6):946-55. PubMed ID: 25739468
    [Abstract] [Full Text] [Related]

  • 38. The structure of the sarcomeric M band: localization of defined domains of myomesin, M-protein, and the 250-kD carboxy-terminal region of titin by immunoelectron microscopy.
    Obermann WM, Gautel M, Steiner F, van der Ven PF, Weber K, Fürst DO.
    J Cell Biol; 1996 Sep 22; 134(6):1441-53. PubMed ID: 8830773
    [Abstract] [Full Text] [Related]

  • 39. Molecular structure of the sarcomeric M band: mapping of titin and myosin binding domains in myomesin and the identification of a potential regulatory phosphorylation site in myomesin.
    Obermann WM, Gautel M, Weber K, Fürst DO.
    EMBO J; 1997 Jan 15; 16(2):211-20. PubMed ID: 9029142
    [Abstract] [Full Text] [Related]

  • 40. The sarcomeric M-band during development and in disease.
    Lange S, Agarkova I, Perriard JC, Ehler E.
    J Muscle Res Cell Motil; 2005 Jan 15; 26(6-8):375-9. PubMed ID: 16470337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.